MARKING MAJOR MILESTONE OF 100,000 PATIENTS TREATED, NORDIC PHARMA, INC. (U.S.) ENHANCES ITS OFFERING AND INCREASES PROVIDER CONVENIENCE BY INCLUDING CANNULAS WITH ITS SHIPMENTS OF LACRIFILL® CANALICULAR GEL FOR TREATMENT OF DRY EYE SYMPTOMS

Nordic Pharma, Inc. is demonstrating this novel therapy at ASCRS BERWYN, Pa., April 9, 2026 /PRNewswire/ -- Nordic Pharma, Inc., a subsidiary of Nordic Group B.V., announces that it is now shipping cannulas along with its syringes of its LACRIFILL® Canalicular Gel, a novel therapy for dry...